Switch to:
AVEO Pharmaceuticals Inc (NAS:AVEO)
EV/EBIT
0.25 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, AVEO Pharmaceuticals Inc's enterprise value is $-26.27 Mil. AVEO Pharmaceuticals Inc's operating income for the trailing twelve months (TTM) ended in Dec. 2013 was $-103.90 Mil. Therefore, AVEO Pharmaceuticals Inc's EV/EBIT ratio for today is 0.25.

AVEO' s 10-Year EV/EBIT Range
Min: 6.3   Max: 16.9
Current: 0.25

6.3
16.9

During the past 7 years, the highest EV/EBIT Ratio of AVEO Pharmaceuticals Inc was 16.90. The lowest was 6.30. And the median was 9.30.

AVEO's EV/EBITis ranked higher than
96% of the 478 Companies
in the Global Biotechnology industry.

( Industry Median: 20.00 vs. AVEO: 0.25 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). AVEO Pharmaceuticals Inc's enterprise value for the quarter that ended in Dec. 2013 was $-4.49 Mil. AVEO Pharmaceuticals Inc's Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was $-103.90 Mil. AVEO Pharmaceuticals Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2013 was 0.00%.


Definition

AVEO Pharmaceuticals Inc's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Operating Income (TTM)
=-26.272/-103.904
=

AVEO Pharmaceuticals Inc's current Enterprise Value is $-26.27 Mil.
AVEO Pharmaceuticals Inc's Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was -33.155 (Mar. 2013 ) + -31.072 (Jun. 2013 ) + -23.608 (Sep. 2013 ) + -16.069 (Dec. 2013 ) = $-103.90 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

AVEO Pharmaceuticals Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2013 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Dec. 2013 )=Operating Income (TTM)/Enterprise Value (Q: Dec. 2013 )
=-103.904/-4.4887
=2,314.79 %

AVEO Pharmaceuticals Inc's Enterprise Value for the quarter that ended in Dec. 2013 was $-4.49 Mil.
AVEO Pharmaceuticals Inc's Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was -33.155 (Mar. 2013 ) + -31.072 (Jun. 2013 ) + -23.608 (Sep. 2013 ) + -16.069 (Dec. 2013 ) = $-103.90 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Operating Income, Earnings Yield (Joel Greenblatt)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

AVEO Pharmaceuticals Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebit 0.000.000.000.000.000.000.0016.110.000.00

AVEO Pharmaceuticals Inc Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
ev2ebit 8.8816.110.000.000.000.000.000.000.000.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide